Substance Use Disorders News

Using etrasimod with opioids or antidepressants did not increase risk for serotonin syndrome-associated adverse events among patients with ulcerative colitis, according to a study published in United European Gastroenterology Journal.

The trajectory of sports gambling over the past several years exhibits strong ties to trends related to alcohol use disorders, results from a cross-sectional survey study showed.

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.

An analysis of recent drug use in the United States revealed unexpected trends in substances being used in tandem with fentanyl, according to an expert.

The American Society of Anesthesiologists released new guidance on the safe use of ketamine for nonanesthesia purposes, such as the treatment of mental health disorders, according to an organization press release.

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation for opioid use disorder and speed up availability of treatment, according to a press release from the manufacturer.

Injectable naltrexone had a more favorable gastrointestinal and liver safety profile compared with other medications for alcohol use disorder, according to a research letter published in Clinical Gastroenterology and Hepatology.

Individuals who required hospital-based care for cannabis use disorder faced nearly three times the risk for premature death, results from a cohort analysis published in JAMA Network Open showed.

Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.